Bladder or kidney-bladder transplant from a deceased donor
Part of Brain & nervous system, Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial offers a first-in-human transplant of a bladder or a kidney combined with a bladder from a deceased donor. It is for people with severe bladder problems or bladder cancer who already need a new bladder or are on immune-suppressing medicines for a prior organ transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a severe bladder problem (like a shrunken or poorly working bladder, or bladder cancer that has not spread to other parts of the body) that requires removal of the bladder.
- You are already taking immune-suppressing medicines for a prior organ transplant, or you need both a new kidney and bladder.
- You are willing and able to do clean intermittent catheterization (emptying your bladder with a tube) by yourself or with help.
- You have no serious infections such as active HIV, hepatitis B or C, or untreated tuberculosis, and no bleeding disorders or connective tissue diseases like severe rheumatoid arthritis or Ehlers-Danlos syndrome.
- You agree to be vaccinated against COVID-19 (or are already fully vaccinated and boosted).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a patient's own tumor cells grown in a lab (organoids) can help choose the best chemotherapy to put directly into the bladder. It is for people with non-muscle invasive bladder cancer who need their first round of this treatment.
This trial tests a new immunotherapy approach for people with a very high risk type of bladder cancer that hasn't spread into the muscle layer. The treatment is guided by a special urine test that looks for tumor DNA, and it may help if surgery cannot remove all the cancer or you choose not to have your bladder removed.
This study tests a combination treatment for people with early-stage bladder cancer who want to avoid bladder removal. It uses a freezing technique (cryoablation) inside the bladder along with immunotherapy drugs to see if this can cure the cancer while keeping the bladder.
This trial tests a combination of an immunotherapy drug (adebrelimab) with two chemotherapy drugs (etoposide and cisplatin) given before surgery for a rare, aggressive type of bladder cancer called neuroendocrine carcinoma. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial uses a lab-grown version of your tumor (an organoid) to see which chemotherapy might work best for you after bladder cancer surgery. It helps doctors choose the most effective treatment for each person.
This early-phase study is testing a combined bladder and kidney transplant approach for people whose bladder problems damage the kidneys. The goal is to see if this treatment can improve bladder and kidney outcomes and be done safely.
Hear when a new Bladder Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.